Vancomycin Resistance in Enterococcus and Staphylococcus aureus.

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Enterococcus faecalis, Enterococcus faecium, and Staphylococcus aureus are common bacteria that can cause serious opportunistic infections.
• These bacteria have developed widespread resistance to antibiotics, including vancomycin, a critical glycopeptide treatment.
• Glycopeptide resistance mechanisms involve genetic mutations and the spread of resistance genes via mobile genetic elements.

Purpose of the Study:

• To review the epidemiology of vancomycin-resistant Enterococcus and S. aureus across various settings.
• To examine the mechanisms of vancomycin resistance, including van and non-van mediated pathways.
• To provide insights into alternative therapeutic strategies for treating infections caused by these drug-resistant bacteria.

Main Methods:

• Literature review of epidemiological data on vancomycin resistance.
• Analysis of genetic mechanisms underlying vancomycin resistance.
• Exploration of current and emerging therapeutic options.

Main Results:

• Vancomycin resistance is prevalent in healthcare, community, and agricultural environments.
• Both intrinsic and acquired resistance mechanisms contribute to vancomycin resistance.
• Alternative treatments are crucial for managing infections caused by resistant strains.

Conclusions:

• Understanding the epidemiology and mechanisms of vancomycin resistance is essential for effective control.
• Development and implementation of alternative therapies are urgently needed to combat resistant Enterococcus and S. aureus infections.
• Multifaceted approaches are required to address the global challenge of antimicrobial resistance.